Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to CSU
Related studies linked through entity extraction aliases.
Related studies linked through entity extraction aliases.